LA
GILD icon

LM Advisors’s Gilead Sciences GILD Stock Holding History

LM Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,533
Closed -$1.52M – 211
2025
Q1 		$1.52M Buy
13,533
+1,518
+13% +$157K 0.27% 66
2024
Q4 		$1.11M Buy
+12,015
New +$1.08M 0.2% 81
2024
Q3 		– Sell
-4,197
Closed -$837K – 176
2024
Q2 		$837K Buy
+4,197
New +$280K 0.15% 95
2024
Q1 		– Sell
-3,494
Closed -$269K – 130
2023
Q4 		$283K Buy
+3,494
New +$272K 0.06% 158

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LM Advisors's GILD Position: Q2 2025 in Review

LM Advisors sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 13,533 shares — an estimated $1.52M sold.

LM Advisors first reported a position in GILD in Q4 2023 and held it in 4 quarters. The position peaked at $1.52M in Q1 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • LM Advisors reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • LM Advisors sold 13,533 Gilead Sciences shares in Q2 2025, an estimated $1.52M.
  • LM Advisors first reported a position in Gilead Sciences in Q4 2023 and held it in 4 quarters.
  • LM Advisors's Gilead Sciences position peaked at $1.52M in Q1 2025.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on LM Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.